Diabetic Foot Consortium - Clinical Research Units (U01)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): January 23, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Purpose: This Funding Opportunity Announcement (FOA) invites applications for Clinical Research Units (CRUs) to form the new Diabetic Foot Consortium (DFC) for multi-site clinical research to validate biomarkers for diabetic foot ulcers that that can predict healing outcomes, guide treatment, and monitor healing and response to treatment. The long-term goal is to lay the foundation for a clinical trial network to test therapies that can improve healing and prevent amputations.
Funds Available: The NIDDK intends to commit $1.5 million in FY 2018 to fund up to 10 awards. In FY 2019 to FY 2021, the NIDDK intends to commit a total of $8.25 million with additional funding anticipated for specific research protocols.
Limited to ONE application
Eligibility: faculty with PI eligibility
The long-term goal is to lay the foundation for a clinical trial network to test therapies that can improve healing and prevent amputations.
Internal submission guidelines:
By Tues., Oct. 31, 2017, 5 p.m., please submit one PDF file containing the following to Jeanne Heschele, Research Management Group (RMG) at email@example.com
1) Title Page
NIDDK Diabetic Foot Consortium - Clinical Research Units (U01) RFA-DK-17-014
PI & Co-PI(s) name, title, department, phone and email address
2) Project summary-up to 4 pages (at least font size 11, single spaced)
3) PI & Co-PI Biosketches